Shift Labs is a Health Care startup founded in 2012 in the United States. The company's slogan, "Enabling Safe and Accurate Infusion Therapy for Anyone, Anywhere," reflects its dedication to providing safe, accurate, and affordable infusion care to a diverse range of individuals, whether they are receiving care at home, in an outpatient infusion center, or in an emerging market. Shift Labs' primary product, the DripAssist Infusion Monitoring platform, has garnered acclaim as an award-winning solution for monitoring gravity IV infusions safely and accurately in any environment. By enhancing the precision of gravity infusions and mitigating the side effects resulting from common errors in infusion rates and volumes, the platform contributes to improved patient well-being and nurse efficiency. Notably, Shift Labs secured a $1.22M Seed Round investment on July 7, 2015, with backing from Investo and Jay Zaveri. This investment emphasizes the market potential and investor confidence in the company's mission to ensure universal access to high-quality infusion care. In summary, Shift Labs stands at the intersection of innovative healthcare technology and social impact, aiming to address critical gaps in infusion therapy, and with notable investment support, it is well-positioned to further its mission of extending high-quality care to all individuals.
No recent news or press coverage available for Shift Labs.